December 2019

December 14, 2019

imipenem/cilastatin plus relebactam was approved for the treatment of cUTIs and cIAIs in adult patients with limited or no available treatment options.

December 13, 2019

In August, the FDA approved lefamulin (Xenleta) for the treatment of CABP after results from 2 phase 3 studies showed that the novel antibiotic was noninferior to existing treatment options.

December 13, 2019

This approval allows ceftolozane/tazobactam to be used to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP).

December 13, 2019

Something novel in infectious diseases practice has occurred and, like many big changes, it is not without controversy.

December 12, 2019

In April, the US Food and Drug Administration (FDA) approved dolutegravir plus lamivudine as a complete 2-drug regimen for treatment naïve adults with HIV-1.

December 12, 2019

As the antibiotic pipeline produces new therapies, clinicians must understand each agent’s specific role in manage­ment of patients infected by multidrug-resistant pathogens.

December 11, 2019

A patient with HIV and skin lesions should trigger a broad differential.

December 10, 2019

If resources and funds were unlimited, what would the ideal stewardship program look like?

December 09, 2019

An epidemiologist explores the changing epidemiology of a familiar disease.

December 06, 2019

Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.

December 05, 2019

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.

December 04, 2019

Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.

December 03, 2019

Bezlotoxumab, a human monoclonal anti­body directed against Clostridioides diffi­cile toxin B, is currently indicated for the prevention of recurrent C diffi­cile infection

December 02, 2019

In 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.

October 03, 2019

A total of 168,420 dental visits included antibiotic prophylaxis, 136,177 (80%) of which were deemed unnecessary.

October 03, 2019

Microarray patches could be key to providing a self-delivery system, that is also discreet, to administer HIV prevention and contraception to women in low-resource settings.

October 02, 2019

Investigators observed no moderate, severe, cumulative, or dose-limiting adverse events leading to discontinuation, and ACX-362E was generally well-tolerated at all dose levels.

October 02, 2019

Investigators assessed rates of all-cause mortality at Day 14 for Cefiderocol and meropenem in patients with nosocomial gram-negative pneumonia.

June 19, 2019

Experts provide community physicians treating HIV with practical advice for screening, diagnosing, and managing patients with HIV.